Navigation Links
Early Stage Drug Delivery Technologies: 62 Profiles of Start-ups and Emerging Companies
Date:4/30/2013

ist-style-type:disc" type="disc">
  • Detailed Technology Description
  • Development Status / Pipeline Products
  • Patents and Publications
  • Partnership and Funding Opportunities
  • Business Development & Licensing Contact

  • Examples of Technologies Presented

    • Mini-pump for subcutaneous delivery of IV medications
    • Targeted nanoparticle micelles
    • Antibody-targeted liposomes
    • Abuse-deterrent delivery system
    • Dry powder particle processing technology
    • Oral capsule technology for biologics
    • Nanovesicle delivery system for delivery across the blood-brain barrier
    • Timed-release intra-ocular implant device
    • Non-invasive aerosol device for brain drug delivery
    • Extracellular drug conjugate technology
    • Nanoparticles and novel device for CNS and inner ear drug delivery
    • Next-generation auto-injector technology
    • Nanopolymer drug conjugates
    • Microneedle patch system
    • Pocket-sized ultrasound delivery device
    • Biodegradable, topical drug patch

    62 Company Profiles (partial listing)

    • Affinity Therapeutics
    • Aquarius Biotechnologies
    • Axxia Pharmaceuticals
    • Blend Therapeutics
    • Clearside Biomedical
    • Cristal Delivery BV
    • DLVR Therapeutics
    • EnduRx Pharmaceuticals
    • Ekteino Laboratories
    • Extend Biosciences
    • Inspiro Medical
    • KAER Biotherapeutics
    • Lauren Sciences, LLC
    • LyoGo LLC
    • Orbis Biosciences
    • ProLynx LLC
    • Prometheon Pharma, LLC
    • Qrono, Inc.
    • scPharmaceuticals, LLC
    • Vaxxas

    + 42 More Companies

    Reasons to Buy

    - Identify early stage delivery technologies that will potentially enable the delivery of your therapeutic c
    '/>"/>

    SOURCE Research and Markets
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related biology technology :

    1. Netsmart Clients to Receive Nearly $2 Million in Meaningful Use EHR Incentive Payments
    2. Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities
    3. VisionGate Uses $2.6 Million NIH Grant to Achieve Full Automation of Cell-CTâ„¢ 3D Imaging System for Early Diagnosis of Cancer
    4. Sequenom Announces 2011 Operational Highlights and Early 2012 Outlook
    5. CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms
    6. Corporate Venturing and Early-Stage Financing in the Spotlight at BioTrinity
    7. Butamax Early Adopters Group surpasses capacity targets with addition of Big River; Membership represents 11 production facilities and nearly 900 million gallons of ethanol capacity
    8. Researchers peek at the early evolution of sex chromosomes
    9. Discuss Early Results of the DIAN Trial at CBIs 6th Annual Alzheimers Drug Development Summit
    10. Early career distinction: Prestigious award recognizes physicists work in electron dynamics
    11. JCI early table of contents for Sept. 4, 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/24/2014)... , July 24, 2014  CorMedix Inc. ... developing and commercializing therapeutic products for the prevention ... announces receipt of notice on July 18, 2014 ... NYSE-MKT has accepted the CorMedix plan to regain ... As a result, the NYSE-MKT is continuing the ...
    (Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
    (Date:7/24/2014)... Md. , July 24, 2014  Spherix Incorporated ... the fostering and monetization of intellectual property, today announced ... the period ending June 30, 2014 on Monday, August ... call at 10 a.m. ET on Monday, August 18, ... be led by the company,s CEO, Anthony Hayes ...
    (Date:7/23/2014)... YORK , July 24, 2014 ... Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First ... "Immune" or "the Company"), announced a collaboration to ... pemphigoid last night at an event attended by ... interested parties. Lyfebulb is a health and wellness ...
    Breaking Biology Technology:CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Spherix Schedules Shareholder Update Call 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5
    ... press release is available in German . ... a central challenge for science and technology. A team ... exploring the concept of "nanostructured storage domains". As the ... Council (CNR) in Bologna (Italy) and Mario Ruben at ...
    ... 27 BioTrends Research Group, Inc. was,named one ... in,the Philadelphia region by the Philadelphia 100(R), a ... the Entrepreneurs, Forum of,Greater Philadelphia, and the Philadelphia ... growth., "This recognition is a testament to ...
    ... ABAX ), a medical products company manufacturing point-of-care,blood ... ended September 30, 2008., Quarterly highlights include:, ... last year,s comparable,quarter., -- Record operating income of ... -- Record medical reagent disc sales of 434,000 units, ...
    Cached Biology Technology:Progress toward new storage media 2Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 2Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 3Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 4Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 5Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 6Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 7Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 8Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009 9
    (Date:7/24/2014)... A multi-institutional team of researchers has developed a new ... safe, noninvasive method for assessing the function and properties ... to better diagnosis and treatment of gut diseases. ... irritable bowel syndrome and inflammatory bowel disease all occur ... effects in patients with diseases such as diabetes and ...
    (Date:7/24/2014)... biodiversity and one of the most species richness biome ... However, current levels of diversity might be still underestimated. ... in the description of new endemic species of this ... availability of samples for DNA analysis. , Using ... morphological analysis, researchers from the University of Richmond ...
    (Date:7/24/2014)... soup in which life arose have been maintained in our ... Anglia. , Research published today in the Journal of ... very likely also in animals still perform ancient reactions thought ... some four billion years ago. , The primordial soup theory ... a result of the combination of metals, gases from the ...
    Breaking Biology News(10 mins):New imaging agent provides better picture of the gut 2A tiny new species of frog from Brazil with a heroic name 2
    ... a tale about a drifting balloon, a newspaper series on ... in rural Montana, and a group of gracefully written stories ... 2009 AAAS Kavli Science Journalism Awards from the American Association ... the first to be given under a new endowment by ...
    ... The drug Sprycel, approved for use by the U.S. ... leukemia, significantly inhibited the growth and invasiveness of ovarian ... by researchers with UCLA,s Jonsson Comprehensive Cancer Center found. ... was even more effective in fighting ovarian cancer in ...
    ... LAS VEGAS, Nov. 9 CBS Vision, the research division ... company, today announced a new research partnership that will allow OMD,s ... the MGM Grand Hotel in Las Vegas. , The new ... the county,s leading agencies, will be called Communications Lab@OMD . ...
    Cached Biology News:Winners of the 2009 AAAS Kavli science journalism awards 2Winners of the 2009 AAAS Kavli science journalism awards 3Winners of the 2009 AAAS Kavli science journalism awards 4Winners of the 2009 AAAS Kavli science journalism awards 5Winners of the 2009 AAAS Kavli science journalism awards 6Winners of the 2009 AAAS Kavli science journalism awards 7Winners of the 2009 AAAS Kavli science journalism awards 8FDA approved leukemia drugs shows promise in ovarian cancer cells 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4
    ... and antibody-based immunoaffinity matrices, such as ... times without compromising antigen-antibody reactivity, the ... agents has precluded the application of ... The CHEMICON Re-Blot Plus Western Blot ...
    Applications: Western blotting ...
    Applications: Western blotting ...
    ...
    Biology Products: